Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
Open Access
- 20 April 2012
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 180 (6), 2490-2503
- https://doi.org/10.1016/j.ajpath.2012.02.024
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer ModelThe American Journal of Pathology, 2011
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1Biochemical Pharmacology, 2010
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cellsBiochemical Pharmacology, 2008
- Chromosome territory reorganization in a human disease with altered DNA methylationProceedings of the National Academy of Sciences, 2007
- Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cellsBiochemical Pharmacology, 2007
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Animal MicroRNAs Confer Robustness to Gene Expression and Have a Significant Impact on 3′UTR EvolutionCell, 2005
- The Microprocessor complex mediates the genesis of microRNAsNature, 2004
- Processing of primary microRNAs by the Microprocessor complexNature, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002